pulmonary involvement Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Unknown (1)

Observational (1)

Assistance Publique - Hôpitaux de Paris (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadraynaud's phenomenon

I am/have/hadskin sclerosis

I am/have/hadraynaud disease

I am/have/hadchest ct

I am/have/hadsclerosis skin

I am/have/hadraynaud's syndrome

I am/have/hadprogressive systemic sclerosis

I am/have/hadchest x-ray

I am/have/hadpulmonary involvement

I am/have/hadscleroderma

added new label for I am/have/had

more

I am looking for

I am looking forcorticosteroids

I am looking forimmunosuppressive agents

I am looking forcyclophosphamide

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Dermatology
Recruiting

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

To define a target value of AUC MPA to improve the modified Rodnan score and / or respiratory impairment (DLCO or FVC) at one year in patients receiving MMF for the treatment of diffuse cutaneous or interstitial lung damage of systemic sclerosis.

raynaud's phenomenon

skin sclerosis

raynaud disease

chest ct

cyclophosphamide

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.